Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratio.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.
Exercise Training in Progressive Multiple Sclerosis: A Comparison of Recumbent Stepping and Body Weight-Supported Treadmill Training.
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
Optic neuritis in multiple sclerosis: Looking from a patient's eyes.
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis.
Quantitative analysis of hindlimbs locomotion kinematics in spinalized rats treated with Tamoxifen plus treadmill exercise.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Alemtuzumab for Multiple Sclerosis.
Large amplitude cortical evoked potentials (EPs) in non-epileptic patients. Reviving an old neurophysiologic tool to help detect CNS Pathology.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.
S100A8/A9: From basic science to clinical application.
The Association Between Multiple Sclerosis and Uveitis.
Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis.
Limbic Pathway Correlates of Cognitive Impairment in Multiple Sclerosis.
Adult Age Differences in Subcortical Myelin Content Are Consistent with Protracted Myelination and Unrelated to Diffusion Tensor Imaging Indices.
Pediatric multiple sclerosis: Cognition and mood.
Pediatric multiple sclerosis: Perspectives from adolescents and their families.